Literature DB >> 24273099

Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination.

S Lumley1, C Atkinson, T Haque.   

Abstract

Entities:  

Keywords:  Immunisation; Infectious Diseases; Respiratory; Virology

Mesh:

Substances:

Year:  2013        PMID: 24273099      PMCID: PMC4518659          DOI: 10.1136/archdischild-2013-305511

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
From 2013 an annual nasal live-attenuated influenza vaccine (LAIV—Fluenz) is available for all children in the UK aged 2 and 3 years and other ‘at-risk’ children, as part of the National Health Service (NHS) childhood vaccination programme.1 2 The vaccine contains reassortant influenza viruses; two influenza A viruses (H1N1 and H3N2) and one influenza B virus,3 and has previously been used in children in the USA. A 2-year-old child presented with respiratory symptoms. PCR assay of nasopharyngeal swab was strongly positive for Rhinovirus (Cycle Threshold, CT 21) and weakly positive for Influenza B (CT 37.6). Further questioning revealed that the child had received the intranasal influenza vaccine 10 days previously. Due to the difference in CT values and detection of an alternative virus (Rhinovirus), a diagnosis of Rhinovirus bronchiolitis was made and the weak Influenza B positivity was attributed to the intranasal vaccine. Immunocompetent children vaccinated with LAIV can shed vaccine viruses for up to 3 weeks (mean duration: 7.6 days); maximal shedding occurs within 2 days of vaccination. Shedding is in lower amounts than with wild-type influenza viruses. Rarely, shed vaccine viruses can be transmitted from vaccine recipients to unvaccinated persons; however, serious illness has not been reported.4 Both wild-type and live-attenuated vaccine virus strains are detected by laboratory respiratory PCR assay. Wild-type and vaccine virus strains could be distinguished by genome sequencing; however, the low copy number of shed vaccine virus precludes this approach. In this case, a clinical decision must be made as to whether the influenza virus is the cause of disease or a consequence of vaccination. This will influence decisions about treating with antivirals. As LAIV is introduced into UK clinical practice, this is a useful reminder to take care in interpreting respiratory PCR results in recently vaccinated children, highlighting the need for a precise vaccination history.
  2 in total

1.  Should all children be immunised against influenza?

Authors:  Valtyr Thors; Calum Smith; Adam Finn
Journal:  Arch Dis Child       Date:  2013-08-01       Impact factor: 3.791

2.  Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2013-09-20
  2 in total
  1 in total

1.  Domination of influenza vaccine virus strains in Hong Kong, 2021.

Authors:  Gannon C K Mak; Stephen S Y Lau; Edman T K Lam; Ken H L Ng; Rickjason C W Chan
Journal:  Influenza Other Respir Viruses       Date:  2022-06-01       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.